SCHEMBL6359211

SCHEMBL6359211

CC(C)(C)OC(=O)C(C)(C)Sc1cccc(Br)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
CTSB P07858 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
MAOA P21397 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 3/20 0.35
NPSR1 Q6W5P4 1/20 0.35
AAK1 Q2M2I8 2/20 0.35
CYP1A2 P05177 1/20 0.35
GAA P10253 1/20 0.35
RECQL P46063 1/20 0.35
PARP1 P09874 1/20 0.34
LMNA P02545 2/20 0.34
MAOB P27338 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727739 0.83 GPR119 (0.38) MAPTMEN1KMT2ASMN1; SMN2PARP1
SCHEMBL3284990 0.82 ALDH1A1 (0.42) MAPTMAOAALDH1A1NPSR1CYP1A2
SCHEMBL3285117 0.81 SMN1; SMN2 (0.41) MAPTCTSSCTSKMEN1KMT2A
SCHEMBL3840925 0.81 PPARA (0.47) MAPTMAOAMEN1KMT2ASMN1; SMN2
SCHEMBL5727003 0.78 CHRNA1 (0.37) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL6361178 0.76 HTR6 (0.46) MAOB
SCHEMBL3484397 0.75 FFAR4 (0.41) SMN1; SMN2ALDH1A1CYP1A2NPC1HTT
SCHEMBL34465856 0.75 MAOA (0.44) MAPTCTSBCTSSCTSKMAOA
SCHEMBL5726793 0.75 AAK1 (0.42) MAPTSMN1; SMN2ALDH1A1NPSR1AAK1
SCHEMBL3346137 0.75 MAOA (0.44) MAPTCTSBCTSSCTSKMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075377-A1 PPAR compounds PFIZER INC 2005-04-07 US disclosed
EP-1372632-A1 PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS Pfizer Products Inc. (US) 2004-01-02 EP disclosed
US-20020169192-A1 PPAR compounds HAYWARD CHERYL M (US) 2002-11-14 US disclosed
WO-2002064130-A1 PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS PFIZER PRODUCTS INC. (US) 2002-08-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169192-A1 PPAR compounds PPARA, PPARG, PPARD MAPT 2750/4885CTSB 3096/4885CTSS 3817/4885
US-20050075377-A1 PPAR compounds PPARA, PPARG, PPARD MAPT 2750/4885CTSB 3096/4885CTSS 3817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.